A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients
Clinical trial NCT03047837 · TERMINATED
Trial details
- NCT number
- NCT03047837
- Sponsor
- Ente Ospedaliero Ospedali Galliera
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-15
- Primary completion
- 2024-03-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.